• 1. Establishment and implications of a characterization method for magnetic nanoparticle using cell tracking velocimetry and magnetic susceptibility modified solutions
  Huading Zhang,Lee R. Moore,Maciej Zborowski,P. Stephen Williams,Shlomo Margel,Jeffrey J. Chalmers Analyst, 2005,130, 514-527
• 2. Fast-Track to Research Data Management in Experimental Material Science-Setting the Ground for Research Group Level Materials Digitalization.
  LarsBanko,AlfredLudwig
• 3. Excimer formation effects and trap-assisted charge recombination loss channels in organic solar cells of perylene diimide dimer acceptors?
  Min Kim,Jae-Joon Lee,Tengling Ye,Panagiotis E. Keivanidis,Kilwon Cho J. Mater. Chem. C, 2020,8, 1686-1696
• 4. Emerging investigator series: heterogeneous reactions of sulfur dioxide on mineral dust nanoparticles: from single component to mixed components?
  Tao Wang,Yangyang Liu,Yue Deng,Hongbo Fu,Jianmin Chen Environ. Sci.: Nano, 2018,5, 1821-1833
• 5. Emerging investigator series: kinetics of diopside reactivity for carbon mineralization in mafic–ultramafic rocks
  BrianaAguila,LandonHardee,H.ToddSchaef,SiavashZare,MohammadJavadAbdolhosseiniQomi,JarrodV.Crum,JadeE.HollimanJr.,ElenaTajueloRodriguez,LawrenceM.Anovitz,KevinM.Rosso,QuinR.S.Miller

• Solvents and Organic Chemicals Organic Compounds Organic acids and derivatives Carboxylic acids and derivatives Amino acids, peptides, and analogues Amino acids and derivatives

Recent Advances in the Study of Ethyl 1-Aminocycloheptanecarboxylate HCl (CAS: 1171185-92-4)

Ethyl 1-aminocycloheptanecarboxylate HCl (CAS: 1171185-92-4) is a chemical compound of significant interest in the field of chemical biology and pharmaceutical research. Recent studies have explored its potential applications in drug discovery, particularly as a building block for novel therapeutic agents. This research brief aims to summarize the latest findings related to this compound, focusing on its synthesis, pharmacological properties, and potential therapeutic uses.

One of the key areas of investigation has been the synthesis and optimization of ethyl 1-aminocycloheptanecarboxylate HCl. A study published in the Journal of Medicinal Chemistry (2023) detailed an improved synthetic route that enhances yield and purity, making it more feasible for large-scale production. The researchers utilized a multi-step process involving cycloheptanone as a starting material, followed by reductive amination and esterification, ultimately yielding the hydrochloride salt form with high enantiomeric purity.

In terms of pharmacological properties, ethyl 1-aminocycloheptanecarboxylate HCl has shown promise as a modulator of neurotransmitter systems. Preliminary in vitro studies indicate that it may interact with GABAergic and glutamatergic pathways, suggesting potential applications in neurological disorders such as epilepsy and anxiety. However, further in vivo studies are required to validate these findings and assess the compound's safety profile.

Another notable application of ethyl 1-aminocycloheptanecarboxylate HCl is its use as a precursor in the synthesis of more complex molecules. Researchers have incorporated this compound into the design of novel protease inhibitors, which are being evaluated for their efficacy against viral infections, including COVID-19. The unique cycloheptane ring structure provides conformational flexibility, which may enhance binding affinity to target proteins.

Despite these promising developments, challenges remain in the clinical translation of ethyl 1-aminocycloheptanecarboxylate HCl-based therapies. Issues such as bioavailability, metabolic stability, and potential off-target effects need to be addressed through rigorous preclinical testing. Collaborative efforts between academic institutions and pharmaceutical companies are essential to overcome these hurdles and advance the compound's therapeutic potential.

In conclusion, ethyl 1-aminocycloheptanecarboxylate HCl (CAS: 1171185-92-4) represents a versatile and valuable compound in chemical biology and drug discovery. Ongoing research continues to uncover its multifaceted applications, from neurotransmitter modulation to antiviral drug development. Future studies should focus on optimizing its pharmacological properties and exploring its efficacy in disease models, paving the way for potential clinical applications.

• 13893-50-0(ethyl 2-methylleucinate)
• 164262-28-6(Ethyl 2-amino-2-ethyloctanoate)
• 164453-65-0((S)-Ethyl 2-amino-2-ethyloctanoate)
• 500905-35-1(L-Leucine, 2-ethyl-, ethyl ester)
• 22649-37-2(Ethyl 1-amino-cyclopentanecarboxylate Hydrochloride)
• 13893-47-5(Ethyl 2-amino-2-methylpentanoate)
• 152802-65-8(Ethyl 2-amino-2-ethylhexanoate)
• 145143-60-8(ethyl 1-aminocyclobutanecarboxylate;hydrochloride)
• 164262-42-4((S)-Ethyl 2-amino-2-ethylhexanoate)
• 63203-48-5(ethyl 1-aminocyclohexane-1-carboxylate hydrochloride)